Pembrolizumab is effective for drugresistant gestational trophoblastic neoplasia
File(s)pembro_for_GTD_20_with_figures_4-10-17.docx (2.18 MB)
Accepted version
Author(s)
Type
Journal Article
Date Issued
2017-11-25
Date Acceptance
2017-11-24
Citation
Lancet, 2017, 390 (10110), pp.2343-2345
ISSN
0140-6736
Publisher
Elsevier
Start Page
2343
End Page
2345
Journal / Book Title
Lancet
Volume
390
Issue
10110
Copyright Statement
© 2017, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
Subjects
Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
PD-L1 EXPRESSION
METASTASES
DISEASES
Publication Status
Published
Date Publish Online
2017-11-24